These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 2447836
1. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. Tanaka N, Inoue F, Takeda I, Mori T, Miyake M, Mimura H, Orita K. Gan To Kagaku Ryoho; 1988 Jan; 15(1):59-66. PubMed ID: 2447836 [Abstract] [Full Text] [Related]
2. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. Miyake M, Hiraki Y, Douke T, Kashitani N, Kondou S, Kimoto S, Hashimoto K, Aono K, Tanaka N, Inoue F. Rinsho Hoshasen; 1988 Jan; 33(1):35-40. PubMed ID: 2452907 [No Abstract] [Full Text] [Related]
3. [CDDP-containing combination chemotherapy for advanced lung cancer]. Asamoto H, Hisa T, Sawano T, Sakai K, Kitamura S, Matsushita N, Kokura M, Satake H, Kawakami I. Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2544-9. PubMed ID: 6210053 [Abstract] [Full Text] [Related]
6. [Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)]. Nishimura M, Sugiura T, Urata A, Ota K. Gan To Kagaku Ryoho; 1985 Jan; 12(1):54-60. PubMed ID: 2578274 [Abstract] [Full Text] [Related]
7. [Clinical study of combination chemotherapy with continuously infused peplomycin (PEP), cis-dichlorodiammineplatinum (II) (CDDP) and mitomycin C (MMC) (PPM therapy)]. Goto T, Furuta I, Urata A, Fukushima M, Okuma K, Oyama A, Murakami M, Ariyoshi Y, Nishimura M, Kurita S. Nihon Gan Chiryo Gakkai Shi; 1983 Dec 20; 18(8):2054-60. PubMed ID: 6201578 [No Abstract] [Full Text] [Related]
8. [Effects of pepleomycin (PEP) infused through bronchial artery for lung cancer: in comparison with the cases of mitomycin (MMC) or carboquon (CQ)]. Yokoyama K, Kaito S, Sobajima T, Fukumoto H, Horiguchi Y, Takeuchi A, Kurokawa A. Gan To Kagaku Ryoho; 1982 Apr 20; 9(4):688-93. PubMed ID: 6191702 [Abstract] [Full Text] [Related]
12. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer. Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H. Cancer Treat Rep; 1985 Sep 20; 69(9):945-51. PubMed ID: 2992785 [Abstract] [Full Text] [Related]
17. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group]. Ohta M, Hara N, Ichikawa Y, Kanda T, Shima K, Tamura K, Hokama M. Gan To Kagaku Ryoho; 1988 Jun 20; 15(6):1901-8. PubMed ID: 2454615 [Abstract] [Full Text] [Related]
18. [Effects of bronchial artery infusion (B-AI) with single use of MMC after intravenous peplomycin (PEP) administration in lung cancer]. Yokoyama K, Takashima T, Nozaki M, Kurokawa A, Matsumoto K. Gan To Kagaku Ryoho; 1985 Feb 20; 12(2):265-9. PubMed ID: 2578769 [Abstract] [Full Text] [Related]
19. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer]. Yasui Y, Suzumori K, Asai H, Yagami Y. Gan No Rinsho; 1985 Sep 20; 31(11):1415-21. PubMed ID: 2415720 [Abstract] [Full Text] [Related]
20. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer]. Fujii M, Kiura K, Okabe K, Toki H, Kimura M. Gan To Kagaku Ryoho; 1987 Sep 20; 14(9):2676-81. PubMed ID: 2820312 [Abstract] [Full Text] [Related] Page: [Next] [New Search]